Top 5 Things To Know About The Lipid Nanoparticle Portfolio

Choosing an ionizable lipid affects how an LNP is built, how it delivers its payload, and how it releases it. This overview looks at a proprietary library of more than 100 ionizable lipids for RNA-LNP therapeutics, with varied biodegradability and a broad pKa range across the cationic head groups. It outlines how lipids are matched to specific applications, drug interactions, and delivery routes, and what proof-of-concept, safety, toxicology, and scale-up data exist across vaccines, protein replacement, gene editing, and ex vivo cell therapy.

Explore the portfolio and see what a collaborative formulation process involves.